332 related articles for article (PubMed ID: 2561904)
1. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
Greene DA; Lattimer-Greene S; Sima AA
Crit Rev Neurobiol; 1989; 5(2):143-219. PubMed ID: 2561904
[TBL] [Abstract][Full Text] [Related]
2. Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?
Greene DA; Lattimer SA; Sima AA
Diabetes; 1988 Jun; 37(6):688-93. PubMed ID: 2838351
[TBL] [Abstract][Full Text] [Related]
3. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications.
Greene DA; Lattimer SA; Sima AA
N Engl J Med; 1987 Mar; 316(10):599-606. PubMed ID: 3027558
[TBL] [Abstract][Full Text] [Related]
4. Role of sorbitol accumulation and myo-inositol depletion in paranodal swelling of large myelinated nerve fibers in the insulin-deficient spontaneously diabetic bio-breeding rat. Reversal by insulin replacement, an aldose reductase inhibitor, and myo-inositol.
Greene DA; Chakrabarti S; Lattimer SA; Sima AA
J Clin Invest; 1987 May; 79(5):1479-85. PubMed ID: 3033025
[TBL] [Abstract][Full Text] [Related]
5. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
[TBL] [Abstract][Full Text] [Related]
6. [Disorders of sorbitol and myoinositol metabolism and the activity of sodium, potassium ATPase in the pathogenesis of peripheral neuropathy in patients with diabetes mellitus].
Mosiewicz J; Grzywa M
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):56-8. PubMed ID: 1329048
[TBL] [Abstract][Full Text] [Related]
7. Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.
Greene DA
Drugs; 1986; 32 Suppl 2():6-14. PubMed ID: 3024950
[TBL] [Abstract][Full Text] [Related]
8. [Diabetic somatic polyneuropathy. Pathogenesis, clinical manifestations and therapeutic concepts].
Hilz MJ; Marthol H; Neundörfer B
Fortschr Neurol Psychiatr; 2000 Jun; 68(6):278-88. PubMed ID: 10923253
[TBL] [Abstract][Full Text] [Related]
9. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.
Sima AA; Nathaniel V; Bril V; McEwen TA; Greene DA
J Clin Invest; 1988 Feb; 81(2):349-64. PubMed ID: 3339124
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of diabetic neuropathies].
Lalau JD; Arlot S; Quichaud J
Ann Med Interne (Paris); 1985; 136(6):486-95. PubMed ID: 3909874
[TBL] [Abstract][Full Text] [Related]
11. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.
Dyck PJ; Sherman WR; Hallcher LM; Service FJ; O'Brien PC; Grina LA; Palumbo PJ; Swanson CJ
Ann Neurol; 1980 Dec; 8(6):590-6. PubMed ID: 7212646
[TBL] [Abstract][Full Text] [Related]
12. A sodium-pump defect in diabetic peripheral nerve corrected by sorbinil administration: relationship to myo-inositol metabolism and nerve conduction slowing.
Greene DA
Metabolism; 1986 Apr; 35(4 Suppl 1):60-5. PubMed ID: 2421135
[TBL] [Abstract][Full Text] [Related]
13. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications.
Del Monte MA; Rabbani R; Diaz TC; Lattimer SA; Nakamura J; Brennan MC; Greene DA
Diabetes; 1991 Oct; 40(10):1335-45. PubMed ID: 1936595
[TBL] [Abstract][Full Text] [Related]
14. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats].
Lu KM; Zhong XL; Zhu XX; Zhu QY
Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis and prevention of diabetic neuropathy and nephropathy.
Greene D
Metabolism; 1988 Feb; 37(2 Suppl 1):25-9. PubMed ID: 2828823
[TBL] [Abstract][Full Text] [Related]
16. Supplemental myo-inositol prevents L-fucose-induced diabetic neuropathy.
Sima AA; Dunlap JA; Davidson EP; Wiese TJ; Lightle RL; Greene DA; Yorek MA
Diabetes; 1997 Feb; 46(2):301-6. PubMed ID: 9000708
[TBL] [Abstract][Full Text] [Related]
17. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.
Sima AA; Lattimer SA; Yagihashi S; Greene DA
J Clin Invest; 1986 Feb; 77(2):474-84. PubMed ID: 3003160
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.
Greene DA; Lattimer SA
Am J Med; 1985 Nov; 79(5A):13-7. PubMed ID: 3000175
[TBL] [Abstract][Full Text] [Related]
19. New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition.
Hotta N
Nagoya J Med Sci; 1997 Nov; 60(3-4):89-100. PubMed ID: 9481088
[TBL] [Abstract][Full Text] [Related]
20. Current aspects of research on the pathogenesis of diabetic neuropathy.
Wuarin-Bierman L; Zahnd GR
Diabete Metab; 1986 Dec; 12(6):319-24. PubMed ID: 3028879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
